Related Experiment Video
Updated: May 15, 2026
05:42
The Forced Swim Test as a Model of Depressive-like Behavior
Published on: March 2, 2015
Future directions for serotonin and antidepressants
1Department of Neurochemistry and Neuropharmacology, Institut d'Investigacions Biomèdiques de Barcelona, Centro de Investigación Biomédica en Red de Salud Mental, Barcelona, Spain. fapnqi@iibb.csic.es
ACS Chemical Neuroscience
|January 22, 2013
Summary
Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) are widely used antidepressants. Their precise neurobiological mechanisms, particularly which serotonin receptors mediate therapeutic effects, remain unclear.
Area of Science:
- Neuroscience
- Pharmacology
- Psychiatry
Background:
- Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) are common antidepressants.
- The exact neurobiological mechanisms underlying their efficacy are not fully understood.
- It is unclear which of the 14 serotonin (5-hydroxytryptamine; 5-HT) receptors are responsible for the therapeutic benefits of SSRIs and SNRIs.
Purpose of the Study:
- To explore the neurobiological basis of antidepressant action.
- To identify the specific serotonin receptors involved in the therapeutic effects of SSRIs and SNRIs.
- To discuss the potential for developing novel antidepressants targeting specific 5-HT receptors.
Main Methods:
- This section summarizes the author's views and does not detail specific experimental methods.
- The discussion is based on existing knowledge of serotonergic systems and antidepressant pharmacology.
- Hypothetical mechanisms and future drug development strategies are considered.
Main Results:
- The precise serotonin receptor subtypes mediating the therapeutic effects of SSRIs and SNRIs are undetermined.
- Increased serotonergic function is hypothesized to improve depressive symptoms.
- Targeting specific 5-HT receptors could potentially overcome limitations of current antidepressants.
Conclusions:
- Further research is needed to elucidate the specific roles of 5-HT receptors in antidepressant action.
- Developing drugs that modulate specific 5-HT receptors may offer improved efficacy and faster onset of action.
- Understanding these mechanisms is crucial for advancing depression treatment.
Related Concept Videos
01:23Antidepressant Drugs: MAOIs and Other Agents
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
01:28Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
01:25Antidepressant Drugs: Overview
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
01:23Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
01:28Drug Therapy
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
01:21G-protein Coupled Receptors
G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.